TIFFANY GILLEN: Open Payments
NPI 1326784877 · STRUTHERS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 46 payments from 9 companies in 2025. Trend: 2023 $1,695 · 2024 $1,813 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $519 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Ardelyx, Inc. | 3 | $63 |
| QOL Medical, LLC | 2 | $52 |
| Madrigal Pharmaceuticals | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $44 |
| Daiichi Sankyo Inc. | 1 | $26 |
| GENZYME CORPORATION | 1 | $25 |
| Celltrion USA Inc. | 1 | $20 |
Products named: RINVOQ, LINZESS, SKYRIZI, ENTYVIO, IBSRELA, Sucraid, CREON, REZDIFFRA.
Industry payments across OH — which companies pay providers there.
